Prognostic differences between atrial fibrillation and atrial flutter.
This report presents the outcome of a cohort of 94 patients with atrial fibrillation from the Canadian Registry of Atrial Fibrillation, in which we paid particular attention to the probability of stroke and death. We also evaluated warfarin use over time and compared left atrial dimensions in patients with atrial flutter with those with atrial fibrillation.
Division of Cardiology, University of Western Ontario, London, Ontario, Canada. paul.lelorier@bmc.org
Paul
P
Lelorier
Karin H
KH
Humphries
Andrew
A
Krahn
Stuart J
SJ
Connolly
Mario
M
Talajic
Martin
M
Green
Robert
R
Sheldon
Paul
P
Dorian
David
D
Newman
Charles R
CR
Kerr
Raymond
R
Yee
George J
GJ
Klein
D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications* / Q000000981:diagnostic imaging / Q000401:mortality*; D001282:Atrial Flutter / Q000150:complications* / Q000000981:diagnostic imaging / Q000401:mortality*; D002170:Canada / Q000453:epidemiology; D015331:Cohort Studies; D005260:Female; D006325:Heart Atria / Q000000981:diagnostic imaging; D006801:Humans; D008297:Male; D008875:Middle Aged; D012042:Registries; D020521:Stroke / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D015996:Survival Rate; D014463:Ultrasonography; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D014859:Warfarin